Swedish-Danish collaboration paid off — the two neighboring countries will be joint hosts of the 10th PCST Conference in the spring of 2008.
This is not only the first time the conference is taking place in the Nordic countries but also the first time it is to be jointly hosted by two countries.
The application was backed by the Swedish Research Council and the Danish Science Communication together with Malmö University College, Lund University, Copenhagen University
In most developed countries safe blood transfusion is taken for granted. But blood grouping is a complex business, and not all blood groups are compatible. In order to check for compatibility, two cross-matching tests are carried out prior to transfusion – but these tests are based on technology that has not changed since the early days of blood transfusions.
Now a consortium called Bloodgen, led by the University of the West of England (UWE), Bristol, is nearing the end of a three-ye
A major international study to test whether a new combination treatment that increases good “HDL” cholesterol prevents heart attacks and strokes will start to recruit patients later this year, it was announced today (Wednesday 31 May).
It will recruit 20,000 patients with vascular disease from the UK, China and Scandinavia to investigate whether combining niacin with a new drug (MK-0524A) that minimises niacin’s side-effects (chiefly facial flushing) can drive down still further t
Patients with Irritable Bowel Syndrome (IBS) who took part in hypnotherapy sessions reported reduced symptoms and improved quality of life, according to research published in the June issue of Journal of Clinical Nursing.
Dr Graeme D Smith from University of Edinburgh studied 75 patients with IBS – which affects up to one in seven adults – before and after they took part in four to five treatment sessions over three months.
He discovered that before the sessions, women wer
Proba-2, currently under development and due for launch in September 2007, is the second in ESA’s series of small, low-cost satellites that are being used to validate new spacecraft technologies while also carrying scientific instruments.
The Proba satellites are part of ESA’s In-Orbit Technology Demonstration Programme, funded through the General Support Technology Programme (GSTP).
The first satellite in the series, Proba-1, was launched in October 2001. Its primary payload
Different disasters require different responses and, in turn, multiple technological solutions, which is a costly duplication of resources. REMSAT II, a project supported by ESA’s Telecommunications Department, has, however, successfully extended its forest fire fighting capabilities to the domain of flood relief, saving both resources and lives.
Already demonstrated to be a big success in aiding Canadian fire-fighters during 2004 (Related news: Using satellites in the fight against fores
The researcher Zafira Castaño has discovered that the loss of a protein in the early phases of lung cancer favors tumor growth. This was the conclusion that the Doctor in Biochemistry reached in the dissertation which she defended at the University of Navarra.
In order to perform the study she began with prior studies from her laboratory, which demonstrated that the protein aCP4 appears in the tissue cells that coat the normal lung, and which, nevertheless, are lost in the first phas
A major fundraising campaign to extend facilities and clinical research programmes for diabetes in Perth and Kinross receives its local launch at Perth Council Chambers on Tuesday May 30th.
Provost Bob Scott will host the reception for the Perth “People’s Launch” of the Diabetes Research Campaign, which has been launched by the University of Dundee and aims to raise £3 million across Tayside.
A key part of the campaign is to provide state-of-the-art clinical research f
COX-1 and COX-2 enzymes may be blocked by pain medications such as Advil and Vioxx in a more complex manner than was previously understood, a Queen’s University study has found.
“The results of the study have potential implications for how we classify the commonly used anti-inflammatory and pain drugs for aches, pains, and fever,” says Colin Funk, a professor of Biochemistry and Physiology at Queen’s and Canada Research Chair in Molecular, Cellular and Physiologiocal Medicine.
Researchers funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Diabetes Association (CDA) have identified an unsuspected role of a protein named SHP-1 that could constitute a new therapeutic path against Type 2 Diabetes.
Under the direction of professor André Marette (Laval University), Nicole Beauchemin (McGill University), Martin Oliver (McGill University Health Centre) and Katherine Siminovitch (University of Toronto) were part of a Canadian and Am
The ease of pronouncing the name of a company and its stock ticker symbol influences how well that stock performs in the days immediately after its initial public offering, two Princeton University psychologists have found.
A new study of initial public offerings (IPOs) on two major American stock exchanges shows that people are more likely to purchase newly offered stocks that have easily pronounced names than those that do not, according to Princeton’s Adam Alter and Dan
Youth with bipolar disorder misread facial expressions as hostile and show heightened neural reactions when they focus on emotional aspects of neutral faces, researchers at the National Institutes of Health’s (NIH) National Institute of Mental Health (NIMH) have discovered. The study provides some of the first clues to the underlying workings of the episodes of mania and depression that disrupt friendships, school, and family life in up to one percent of children.
Brain scans showed tha
With world energy prices and climate-altering greenhouse gas emissions ballooning in tandem with a surge in energy demand from the hot economies of China, India and Brazil, the world has a major stake in the success of energy reduction efforts, particularly in those three countries, warn experts concluding a four-year international project.
Without significant gains from energy efficiency efforts, China, India and Brazil within a single human generation (by 2030) will more than
A rare genetic defect that can trigger a host of diseases from type 1 diabetes to alopecia has helped explain the imbalance of immune regulator and killer cells in autoimmune disease.
Mutation in the Aire gene causes APS1, a disease causing two out of three problems – an underactive parathyroid, yeast infection of the skin and/or mucous membrane and adrenal gland insufficiency – by age 5 and up to 16 autoimmune diseases over a lifetime.
The same mutation causes a defec
A study led by UCSF neurologist S. Claiborne Johnston, MD, has shown that coiling of ruptured brain aneurysms is very effective during long-term follow-up, similar to outcomes with surgical clipping.
Although results of a previous trial suggested that coiling was superior to surgical clipping one year after treatment, a lack of data on long-term outcomes has been a major concern, according to Johnston. The study results are published in the June 2006 issue of the journal Strok
For Dr. Sydney Finegold, research is like reading a really good mystery or detective story. “But it is real life and one can see the results in one’s own patients,” he said. “So, one can have great fun while accomplishing worthwhile things.”
With a grant from the Department of Defense, Finegold has taken his passion for research and applied it to a problem that affects civilians as well as injured service members: wound bacteria.
“The flora of wound infections is v
Feedback
